140 related articles for article (PubMed ID: 9755864)
41. Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin.
Shone CC; Quinn CP; Wait R; Hallis B; Fooks SG; Hambleton P
Eur J Biochem; 1993 Nov; 217(3):965-71. PubMed ID: 8223654
[TBL] [Abstract][Full Text] [Related]
42. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.
Binz T; Blasi J; Yamasaki S; Baumeister A; Link E; Südhof TC; Jahn R; Niemann H
J Biol Chem; 1994 Jan; 269(3):1617-20. PubMed ID: 8294407
[TBL] [Abstract][Full Text] [Related]
43. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.
Bajohrs M; Rickman C; Binz T; Davletov B
EMBO Rep; 2004 Nov; 5(11):1090-5. PubMed ID: 15486565
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival.
Peng L; Liu H; Ruan H; Tepp WH; Stoothoff WH; Brown RH; Johnson EA; Yao WD; Zhang SC; Dong M
Nat Commun; 2013; 4():1472. PubMed ID: 23403573
[TBL] [Abstract][Full Text] [Related]
45. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
46. Modulation of L-type Ca(2+) channels by distinct domains within SNAP-25.
Ji J; Yang SN; Huang X; Li X; Sheu L; Diamant N; Berggren PO; Gaisano HY
Diabetes; 2002 May; 51(5):1425-36. PubMed ID: 11978639
[TBL] [Abstract][Full Text] [Related]
47. Disruption of syntaxin-mediated protein interactions blocks neurotransmitter secretion.
O'Connor V; Heuss C; De Bello WM; Dresbach T; Charlton MP; Hunt JH; Pellegrini LL; Hodel A; Burger MM; Betz H; Augustine GJ; Schäfer T
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12186-91. PubMed ID: 9342384
[TBL] [Abstract][Full Text] [Related]
48. Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues.
O'Sullivan GA; Mohammed N; Foran PG; Lawrence GW; Oliver Dolly J
J Biol Chem; 1999 Dec; 274(52):36897-904. PubMed ID: 10601242
[TBL] [Abstract][Full Text] [Related]
49. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
50. Multiple forms of SNARE complexes in exocytosis from chromaffin cells: effects of Ca(2+), MgATP and botulinum toxin type A.
Lawrence GW; Dolly JO
J Cell Sci; 2002 Feb; 115(Pt 3):667-73. PubMed ID: 11861772
[TBL] [Abstract][Full Text] [Related]
51. Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation.
Meunier FA; Lisk G; Sesardic D; Dolly JO
Mol Cell Neurosci; 2003 Apr; 22(4):454-66. PubMed ID: 12727443
[TBL] [Abstract][Full Text] [Related]
52. The C-terminal transmembrane region of synaptobrevin binds synaptophysin from adult synaptic vesicles.
Yelamanchili SV; Reisinger C; Becher A; Sikorra S; Bigalke H; Binz T; Ahnert-Hilger G
Eur J Cell Biol; 2005 Apr; 84(4):467-75. PubMed ID: 15900706
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of neurotransmitter release by synthetic proline-rich peptides shows that the N-terminal domain of vesicle-associated membrane protein/synaptobrevin is critical for neuro-exocytosis.
Cornille F; Deloye F; Fournié-Zaluski MC; Roques BP; Poulain B
J Biol Chem; 1995 Jul; 270(28):16826-32. PubMed ID: 7622497
[TBL] [Abstract][Full Text] [Related]
54. Molecular analysis of SNAP-25 function in exocytosis.
Graham ME; Washbourne P; Wilson MC; Burgoyne RD
Ann N Y Acad Sci; 2002 Oct; 971():210-21. PubMed ID: 12438121
[TBL] [Abstract][Full Text] [Related]
55. Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitro.
Lawrence GW; Wang J; Brin MF; Aoki KR; Wheeler L; Dolly JO
FEBS J; 2014 Jul; 281(14):3243-60. PubMed ID: 24863955
[TBL] [Abstract][Full Text] [Related]
56. The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.
Keller JE; Neale EA
J Biol Chem; 2001 Apr; 276(16):13476-82. PubMed ID: 11278807
[TBL] [Abstract][Full Text] [Related]
57. SNAP-25.
Hodel A
Int J Biochem Cell Biol; 1998 Oct; 30(10):1069-73. PubMed ID: 9785471
[TBL] [Abstract][Full Text] [Related]
58. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
59. Molecular scaffold reorganization at the transmitter release site with vesicle exocytosis or botulinum toxin C1.
Stanley EF; Reese TS; Wang GZ
Eur J Neurosci; 2003 Oct; 18(8):2403-7. PubMed ID: 14622203
[TBL] [Abstract][Full Text] [Related]
60. Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.
Anne C; Turcaud S; Blommaert AG; Darchen F; Johnson EA; Roques BP
Chembiochem; 2005 Aug; 6(8):1375-80. PubMed ID: 15988765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
